213 related articles for article (PubMed ID: 21281469)
1. Effects of EpCAM overexpression on human breast cancer cell lines.
Gostner JM; Fong D; Wrulich OA; Lehne F; Zitt M; Hermann M; Krobitsch S; Martowicz A; Gastl G; Spizzo G
BMC Cancer; 2011 Jan; 11():45. PubMed ID: 21281469
[TBL] [Abstract][Full Text] [Related]
2. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.
Yamashita T; Budhu A; Forgues M; Wang XW
Cancer Res; 2007 Nov; 67(22):10831-9. PubMed ID: 18006828
[TBL] [Abstract][Full Text] [Related]
3. Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines.
Martowicz A; Spizzo G; Gastl G; Untergasser G
BMC Cancer; 2012 Oct; 12():501. PubMed ID: 23110550
[TBL] [Abstract][Full Text] [Related]
4. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy.
Osta WA; Chen Y; Mikhitarian K; Mitas M; Salem M; Hannun YA; Cole DJ; Gillanders WE
Cancer Res; 2004 Aug; 64(16):5818-24. PubMed ID: 15313925
[TBL] [Abstract][Full Text] [Related]
5. EpCAM modulates NF-κB signaling and interleukin-8 expression in breast cancer.
Sankpal NV; Fleming TP; Gillanders WE
Mol Cancer Res; 2013 Apr; 11(4):418-26. PubMed ID: 23378578
[TBL] [Abstract][Full Text] [Related]
6. EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2(+), basal-like, and HER2 intrinsic subtypes of breast cancer.
Soysal SD; Muenst S; Barbie T; Fleming T; Gao F; Spizzo G; Oertli D; Viehl CT; Obermann EC; Gillanders WE
Br J Cancer; 2013 Apr; 108(7):1480-7. PubMed ID: 23519058
[TBL] [Abstract][Full Text] [Related]
7. Members of the EpCAM signalling pathway are expressed in gastric cancer tissue and are correlated with patient prognosis.
Warneke VS; Behrens HM; Haag J; Krüger S; Simon E; Mathiak M; Ebert MP; Röcken C
Br J Cancer; 2013 Oct; 109(8):2217-27. PubMed ID: 24008668
[TBL] [Abstract][Full Text] [Related]
8. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
Benhaj K; Akcali KC; Ozturk M
Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
[TBL] [Abstract][Full Text] [Related]
9. Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion.
Sankpal NV; Mayfield JD; Willman MW; Fleming TP; Gillanders WE
Breast Cancer Res; 2011; 13(6):R124. PubMed ID: 22132731
[TBL] [Abstract][Full Text] [Related]
10. High-throughput screening for identification of inhibitors of EpCAM-dependent growth of hepatocellular carcinoma cells.
Henrich CJ; Budhu A; Yu Z; Evans JR; Goncharova EI; Ransom TT; Wang XW; McMahon JB
Chem Biol Drug Des; 2013 Aug; 82(2):131-9. PubMed ID: 23879724
[TBL] [Abstract][Full Text] [Related]
11. EpCAM overexpression prolongs proliferative capacity of primary human breast epithelial cells and supports hyperplastic growth.
Martowicz A; Rainer J; Lelong J; Spizzo G; Gastl G; Untergasser G
Mol Cancer; 2013 Jun; 12():56. PubMed ID: 23758908
[TBL] [Abstract][Full Text] [Related]
12. MTA1-upregulated EpCAM is associated with metastatic behaviors and poor prognosis in lung cancer.
Zhou N; Wang H; Liu H; Xue H; Lin F; Meng X; Liang A; Zhao Z; Liu Y; Qian H
J Exp Clin Cancer Res; 2015 Dec; 34():157. PubMed ID: 26698569
[TBL] [Abstract][Full Text] [Related]
13. Expression of EpCAM and Wnt/ β-catenin in human colon cancer.
Zhou FQ; Qi YM; Xu H; Wang QY; Gao XS; Guo HG
Genet Mol Res; 2015 May; 14(2):4485-94. PubMed ID: 25966221
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional repression of epithelial cell adhesion molecule contributes to p53 control of breast cancer invasion.
Sankpal NV; Willman MW; Fleming TP; Mayfield JD; Gillanders WE
Cancer Res; 2009 Feb; 69(3):753-7. PubMed ID: 19141643
[TBL] [Abstract][Full Text] [Related]
15. Claudin-7 regulates EpCAM-mediated functions in tumor progression.
Nübel T; Preobraschenski J; Tuncay H; Weiss T; Kuhn S; Ladwein M; Langbein L; Zöller M
Mol Cancer Res; 2009 Mar; 7(3):285-99. PubMed ID: 19276185
[TBL] [Abstract][Full Text] [Related]
16. By inhibiting Ras/Raf/ERK and MMP-9, knockdown of EpCAM inhibits breast cancer cell growth and metastasis.
Gao J; Liu X; Yang F; Liu T; Yan Q; Yang X
Oncotarget; 2015 Sep; 6(29):27187-98. PubMed ID: 26356670
[TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3β/β-Catenin Signaling Pathway.
Zhang X; Zhong S; Xu Y; Yu D; Ma T; Chen L; Zhao Y; Chen X; Yang S; Wu Y; Tang J; Zhao J
PLoS One; 2016; 11(4):e0153194. PubMed ID: 27045586
[TBL] [Abstract][Full Text] [Related]
19. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of EpCAM enhances the chemosensitivity of breast cancer cells to 5-fluorouracil by downregulating the antiapoptotic factor Bcl-2.
Gao J; Yan Q; Liu S; Yang X
PLoS One; 2014; 9(7):e102590. PubMed ID: 25019346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
